Management of Axillary Disease

被引：34

作者：

Caudle, Abigail S. ^{[1
]}

Cupp, Julie A. ^{[1
]}

Kuerer, Henry M. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77230 USA

来源：

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2014年 / 23卷 / 03期

关键词：

Breast cancer; Nodal metastasis; Sentinel lymph node; Axillary lymphadenectomy; Neoadjuvant chemotherapy; BREAST-CANCER PATIENTS; LYMPH-NODE BIOPSY; FINE-NEEDLE-ASPIRATION; NEOADJUVANT CHEMOTHERAPY; SENTINEL-NODE; POSTOPERATIVE RADIOTHERAPY; PREOPERATIVE CHEMOTHERAPY; RADIATION-THERAPY; CLINICAL-PRACTICE; AMERICAN-SOCIETY;

D O I：

10.1016/j.soc.2014.03.007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The presence of nodal metastases is the most important prognostic indicator in breast cancer, making accurate assessment of the axillary nodal basin critical to delivering optimal therapy in breast cancer. Clinically node-negative women can be reliably staged in a minimally invasive manner using sentinel lymph node dissection (SLND). In node-negative patients receiving neoadjuvant chemotherapy, SLND can be performed after chemotherapy, allowing for a single surgical procedure and a decreased probability of requiring axillary lymph node dissection (ALND). Clinically node-positive patients are currently recommended to undergo ALND, although these recommendations may change with emerging trial data.

引用

页码：473 / +

页数：15

共 59 条

[1]

Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0

[2] Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer [J].

Beenken, SW ;

Urist, MM ;

Zhang, YT ;

Desmond, R ;

Krontiras, H ;

Medina, H ;

Bland, KI .

ANNALS OF SURGERY, 2003, 237 (05) :732-738

[3] Comparison of Sentinel Lymph Node Biopsy Alone and Completion Axillary Lymph Node Dissection for Node-Positive Breast Cancer [J].

Bilimoria, Karl Y. ;

Bentrem, David J. ;

Hansen, Nora M. ;

Bethke, Kevin P. ;

Rademaker, Alfred W. ;

Ko, Clifford Y. ;

Winchester, David P. ;

Winchester, David J. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18) :2946-2953

[4]

Boughey JC, 2012, CANCER RES, V72, p94s

[5] Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer The ACOSOG Z1071 (Alliance) Clinical Trial [J].

Boughey, Judy C. ;

Suman, Vera J. ;

Mittendorf, Elizabeth A. ;

Ahrendt, Gretchen M. ;

Wilke, Lee G. ;

Taback, Bret ;

Leitch, A. Marilyn ;

Kuerer, Henry M. ;

Bowling, Monet ;

Flippo-Morton, Teresa S. ;

Byrd, David R. ;

Ollila, David W. ;

Julian, Thomas B. ;

McLaughlin, Sarah A. ;

McCall, Linda ;

Symmans, W. Fraser ;

Le-Petross, Huong T. ;

Haffty, Bruce G. ;

Buchholz, Thomas A. ;

Nelson, Heidi ;

Hunt, Kelly K. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (14) :1455-1461

[6]

CABANAS RM, 1977, CANCER-AM CANCER SOC, V39, P456, DOI 10.1002/1097-0142(197702)39:2<456::AID-CNCR2820390214>3.0.CO

[7]

2-I

[8] Application of ACOSOG Z0011 Criteria Reduces Perioperative Costs [J].

Camp, Melissa S. ;

Greenup, Rachel A. ;

Taghian, Alphonse ;

Coopey, Suzanne B. ;

Specht, Michelle ;

Gadd, Michele ;

Hughes, Kevin ;

Smith, Barbara L. .

ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (03) :836-841

[9]

CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO

[10]

2-H

← 1 2 3 4 5 6 →